<qa>  What is the risk of relapse at a minimum of 5 years after all therapy?- Patients with a concurrently active second malignancy other than non- melanoma skin cancers or in situ cervical cancer are excluded; patients are not considered to have a concurrently active malignancy if they have completed therapy and considered by their physician to be at less than 30 risk of relapse at a minimum of 5 years after all therapy 